cGxP.wire https://validator.w3.org/feed/docs/rss2.html ImmunityBio Reports Long-Term ANKTIVA Data in Bladder Cancer Alcon Wins FDA Approval for BRYTLY Redness-Relief Eye Drops Opus Genetics Wins FDA Approval for RYZUMVI in Presbyopia Organon Reports Positive Six-Year MIUDELLA Phase 3 Results Tiziana Completes Dosing Initiation in Phase 2 Alzheimer’s Trial Regeneron’s Libtayo Recommended for Updated EU Dosing Regimen Genentech Wins FDA Approval for Enspryng in Thyroid Eye Disease Ionis Pharmaceuticals Wins EU CHMP Support for TRYNGOLZA in sHTG Cellectar Biosciences Reports Strong Iopofosine Phase 2b Results Aquestive Therapeutics Wins FDA Acceptance for Anaphylm NDA Resubmission Eikon Therapeutics Submits IND for Prostate Cancer Drug EIK1006 NRx Pharmaceuticals Receives FDA Labeling Review Letter Legend Biotech Wins FDA IND Clearance for LB2501 In Vivo CAR-T Opus Genetics Reports Positive Gene Therapy Data in 2026 MacroGenics Doses First Patient in MGC030 Phase 1 Trial Spectrum Dynamics Advances All-Energy Digital SPECT/CT SimBioSys Wins FDA Clearance for AI Breast Cancer Risk Tool TranspireBio CEO Highlights FDA Generic Inhaler Framework Marengo Wins Second FDA Fast Track for Invikafusp Alfa Philips Launches EXIT-CVD Studies to Advance Heart Care Elevar Resubmits FDA Application for Liver Cancer Therapy SAB BIO Wins FDA Fast Track for SAB-142 Diabetes Therapy Takeda Reports Positive TAK-881 Phase 2/3 Trial Results Vanda Pharmaceuticals Reports VQW-765 Phase III Results CU Anschutz Study Shows CGM Benefits in Type 2 Diabetes Enliven Therapeutics Names Kristine Ball to Board Leadership Alvotech and Advanz File Eylea 8 mg Biosimilar Application Phanes Therapeutics Doses First CRC Patient With Spevatamig Enodia Therapeutics and Pfizer Sign $500M Drug Discovery Deal Oncolytics Biotech Updates GOBLET Cancer Study Data Timeline Crescent Biopharma Advances CR-001 and ADC Cancer Pipeline Leads Biolabs Doses First Patient in Colorectal Cancer Trial Roche Wins FDA Approval for Enspryng in Thyroid Eye Disease insitro and AstraZeneca Partner on AI Drug Discovery Kedrion Calls for Earlier Diagnosis of Immune Deficiencies EltaMD Launches New Serum and Cream for Skin Recovery OMass Therapeutics Raises $310M to Advance Drug Pipeline Lunit AI Reveals HER2 Patterns Linked to Cancer Response Krystal Biotech Reports Broad BCC Regression With KB113 Immunocore Doses First Patient in Type 1 Diabetes Trial Salvia BioElectronics Begins Pivotal U.S. Trial of Migraine Implant Cellectar Reports Strong Iopofosine Data in Waldenström Macroglobulinemia Aquestive FDA Accepts Anaphylm NDA Resubmission for Review Seres Therapeutics Advances SER-428 for Bloodstream Infection Prevention Galderma Reports Year-Long Nemolizumab Benefits in Children Merz Completes Recruitment in Phase III XEOMIN Migraine Trials Vividion Launches Phase 2 Trial of WRN Inhibitor VVD-214 Mission Therapeutics Doses First Patient in MTX325 Parkinson’s Trial Viking Therapeutics Starts Oral VK2735 Phase 3 Obesity Trials Genezen and Galibra Advance SSADH Deficiency Gene Therapy